Cytomegalovirus (CMV) is a common virus for people of all ages. Though most children and adults don’t experience symptoms, CMV infection before or during birth in newborns (congenital CMV infection) can result in significant lifelong disability. CMV is the most common infectious cause of birth defects in the U.S.
About 1 out of 200 babies is born with congenital CMV infection, and 1 out of 5 babies with congenital CMV infection will have symptoms or long-term health problems, such as hearing loss. Researchers are now studying an investigational CMV vaccine.
- Must be age 18-50 and generally healthy
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.
Submit your information
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.